New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers

YE Nikiforov, L Yip, MN Nikiforova - Clinical cancer research, 2013 - AACR
Thyroid cancer is the most common type of endocrine malignancy, with approximately
55,000 new cases diagnosed in the United States in 2012. However, thyroid nodules are …

Molecular profiling of thyroid nodule fine-needle aspiration cytology

M Eszlinger, L Lau, S Ghaznavi, C Symonds… - Nature Reviews …, 2017 - nature.com
The differential diagnosis and malignancy risk stratification of thyroid nodules requires
multidisciplinary expertise and knowledge of both local ultrasonography practices and the …

The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology

G Kouniavsky, MA Zeiger - Journal of surgical oncology, 2012 - Wiley Online Library
Thyroid nodules are very common and fine needle aspiration (FNA) is a very sensitive
means of diagnosis. However, its limitations include the fact that the cytology reports are …

Diagnosis of thyroid cancer: state of art

M Boufraqech, D Patel, Y Xiong… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Thyroid cancer is the most common endocrine cancer in the USA and its
incidence is increasing worldwide. Thyroid fine-needle aspiration biopsy (FNA) and …

Role of molecular markers in thyroid nodule management: then and now

YE Nikiforov - Endocrine Practice, 2017 - Elsevier
Objective: To describe the evolution and clinical utility of molecular testing for thyroid
nodules and cancer achieved over the last 2 decades. Methods: Scientific reports on thyroid …

[HTML][HTML] European thyroid association guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics

R Paschke, S Cantara, A Crescenzi… - European thyroid …, 2017 - etj.bioscientifica.com
Molecular fine-needle aspiration (FNA) cytology diagnostics has the potential to address the
inherent limitation of FNA cytology which is an indeterminate (atypia of undetermined …

[HTML][HTML] Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready?

RM Melillo, M Santoro, G Vecchio - F1000 medicine reports, 2010 - ncbi.nlm.nih.gov
Thyroid nodules are a very common clinical finding, and although the majority of them are
benign, thyroid carcinoma accounts for about 5-15% of nodules. Fine-needle aspiration …

[HTML][HTML] Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities

J Patel, J Klopper, EE Cottrill - Frontiers in endocrinology, 2023 - frontiersin.org
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …

Diagnostic biomarkers of differentiated thyroid cancer

T Kunavisarut - Endocrine, 2013 - Springer
The incidence of thyroid cancer has been increasing all around the world in the past
decades. Early detection is one of the keys to reduce the mortality. Currently, fine-needle …

What is new on thyroid cancer biomarkers

RM Ruggeri, A Campennì, S Baldari… - Biomarker …, 2008 - journals.sagepub.com
Thyroid cancer harbours in about 5% of thyroid nodules. The majority of them are well-
differentiated cancers originating from the follicular epithelium, and are subdivided into …